Skip to main content
SpringerLink
Log in

Platelet Receptors

  • Chapter
  • First Online:
Antiplatelet Agents

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 210))

Abstract

Well-understood functions for “traditional” platelet receptors are described, but “newer” receptors are equally discussed. Receptors are described biochemically (structure, ligand(s), protein partners, and function) and whenever possible, their clinical importance (mutations, polymorphisms, syndrome) are highlighted.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdullah NM, Kachman M, Walker A, Hawley AE, Wrobleski SK, Myers DD, Strahler JR, Andrews PC, Michailidis GC, Ramacciotti E, Henke PK, Wakefield TW (2009) Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study. Clin Appl Thromb Hemost 15:201–208

    PubMed  CAS  Google Scholar 

  • Adam F, Bouton MC, Huisse MG, Jandrot-Perrus M (2003) Thrombin interaction with platelet membrane glycoprotein Ib alpha. Trends Mol Med 9:461–464

    Article  PubMed  CAS  Google Scholar 

  • Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, Herbert JM, Lemke G, Goff SP, Matsushima GK, Earp HS, Vesin C, Hoylaerts MF, Plaisance S, Collen D, Conway EM, Wehrle-Haller B, Carmeliet P (2005) Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest 115:237–246

    PubMed  CAS  Google Scholar 

  • Arthur JF, Dunkley S, Andrews RK (2007) Platelet glycoprotein VI-related clinical defects. Br J Haematol 139:363–372

    Article  PubMed  CAS  Google Scholar 

  • Autschbach F, Palou E, Mechtersheimer G, Rohr C, Pirotto F, Gassler N, Otto HF, Schraven B, Gaya A (1999) Expression of the membrane protein tyrosine phosphatase CD148 in human tissues. Tissue Antigens 54:485–498

    Article  PubMed  CAS  Google Scholar 

  • Baglia FA, Badellino KO, Li CQ, Lopez JA, Walsh PN (2002) Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 277:1662–1668

    Article  PubMed  CAS  Google Scholar 

  • Bender M, Hofmann S, Stegner D, Chalaris A, Bosl M, Braun A, Scheller J, Rose-John S, Nieswandt B (2010) Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 116:3347–3355

    Article  PubMed  CAS  Google Scholar 

  • Bradford HN, Pixley RA, Colman RW (2000) Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 275:22756–22763

    Article  PubMed  CAS  Google Scholar 

  • Clemetson KJ, Clemetson JM (2001) Platelet collagen receptors. Thromb Haemost 86:189–197

    PubMed  CAS  Google Scholar 

  • Coller BS, Shattil SJ (2008) The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 112:3011–3025

    Article  PubMed  CAS  Google Scholar 

  • Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW (2006) Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 108:3045–3052

    Article  PubMed  CAS  Google Scholar 

  • Cosemans JM, Iserbyt BF, Deckmyn H, Heemskerk JW (2008) Multiple ways to switch platelet integrins on and off. J Thromb Haemost 6:1253–1261

    Article  PubMed  CAS  Google Scholar 

  • Cosemans JM, Van Kruchten R, Olieslagers S, Schurgers LJ, Verheyen FK, Munnix IC, Waltenberger J, Angelillo-Scherrer A, Hoylaerts MF, Carmeliet P, Heemskerk JW (2010) Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization. J Thromb Haemost 8:1797–1808

    Article  PubMed  CAS  Google Scholar 

  • De Marco L, Mazzucato M, Masotti A, Ruggeri ZM (1994) Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. J Biol Chem 269:6478–6484

    PubMed  Google Scholar 

  • Devreese K, Peerlinck K, Hoylaerts MF (2010) Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants. Blood 115:870–878

    Article  PubMed  CAS  Google Scholar 

  • Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, Ajzenberg N, Grandchamp B, Jandrot-Perrus M (2009) Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 114:1900–1903

    Article  PubMed  CAS  Google Scholar 

  • Ellison S, Mori J, Barr AJ, Senis YA (2010) CD148 enhances platelet responsiveness to collagen by maintaining a pool of active Src family kinases. J Thromb Haemost 8:1575–1583

    Article  PubMed  CAS  Google Scholar 

  • Fang J, Jensen ES, Boudreaux MK, Du LM, Hawkins TB, Koukouritaki SB, Cornetta K, Wilcox DA (2011) Platelet gene therapy improves hemostatic function for integrin {alpha}IIb{beta}3-deficient dogs. Proc Natl Acad Sci USA 108(23):9583–9588

    Article  PubMed  CAS  Google Scholar 

  • Fiore M, Pillois X, Nurden P, Nurden AT, Austerlitz F (2011) Founder effect and estimation of the age of the French Gypsy mutation associated with Glanzmann thrombasthenia in Manouche families. Eur J Hum Genet 19(9):981–987

    Article  PubMed  Google Scholar 

  • Franchini M, Montagnana M, Lippi G (2008) Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease. Int J Lab Hematol 30:91–94

    Article  PubMed  CAS  Google Scholar 

  • Freson K, Hashimoto H, Thys C, Wittevrongel C, Danloy S, Morita Y, Shintani N, Tomiyama Y, Vermylen J, Hoylaerts MF, Baba A, Van Geet C (2004) The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. J Clin Invest 113:905–912

    PubMed  CAS  Google Scholar 

  • Gachet C (2008) P2 receptors, platelet function and pharmacological implications. Thromb Haemost 99:466–472

    PubMed  CAS  Google Scholar 

  • Ghosh A, Murugesan G, Chen K, Zhang L, Wang Q, Febbraio M, Anselmo RM, Marchant K, Barnard J, Silverstein RL (2011) Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood 117:6355–6366

    Article  PubMed  CAS  Google Scholar 

  • Giomarelli B, Washington VA, Chisholm MM, Quigley L, McMahon JB, Mori T, McVicar DW (2007) Inhibition of thrombin-induced platelet aggregation using human single-chain Fv antibodies specific for TREM-like transcript-1. Thromb Haemost 97:955–963

    PubMed  CAS  Google Scholar 

  • Goschnick MW, Lau LM, Wee JL, Liu YS, Hogarth PM, Robb LM, Hickey MJ, Wright MD, Jackson DE (2006) Impaired “outside-in” integrin alphaIIbbeta3 signaling and thrombus stability in TSSC6-deficient mice. Blood 108:1911–1918

    Article  PubMed  CAS  Google Scholar 

  • Gross S, Tilly P, Hentsch D, Vonesch JL, Fabre JE (2007) Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors. J Exp Med 204:311–320

    Article  PubMed  CAS  Google Scholar 

  • Habib A, FitzGerald GA, Maclouf J (1999) Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J Biol Chem 274:2645–2651

    Article  PubMed  CAS  Google Scholar 

  • Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K (2009) A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost 7:1356–1363

    Article  PubMed  CAS  Google Scholar 

  • Herrera-Galeano JE, Becker DM, Wilson AF, Yanek LR, Bray P, Vaidya D, Faraday N, Becker LC (2008) A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability. Arterioscler Thromb Vasc Biol 28:1484–1490

    Article  PubMed  CAS  Google Scholar 

  • Hirata T, Ushikubi F, Kakizuka A, Okuma M, Narumiya S (1996) Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 97:949–956

    Article  PubMed  CAS  Google Scholar 

  • Hoylaerts MF, Yamamoto H, Nuyts K, Vreys I, Deckmyn H, Vermylen J (1997) von Willebrand factor binds to native collagen VI primarily via its A1 domain. Biochem J 324(Pt 1):185–191

    PubMed  CAS  Google Scholar 

  • Hu H, Hoylaerts MF (2010) The P2X1 ion channel in platelet function. Platelets 21:153–166

    Article  PubMed  CAS  Google Scholar 

  • Hughes CE, Navarro-Nunez L, Finney BA, Mourao-Sa D, Pollitt AY, Watson SP (2010) CLEC-2 is not required for platelet aggregation at arteriolar shear. J Thromb Haemost 8:2328–2332

    Article  PubMed  CAS  Google Scholar 

  • Ibrahim S, Tetruashvily M, Frey AJ, Wilson SJ, Stitham J, Hwa J, Smyth EM (2010) Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 30:1802–1809

    Article  PubMed  CAS  Google Scholar 

  • Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, Lin SJ, Kraja AT, Province MA, Yang Q, Becker DM, O’Donnell CJ, Becker LC (2010) Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 42:608–613

    Article  PubMed  CAS  Google Scholar 

  • Jones CI, Bray S, Garner SF, Stephens J, de Bono B, Angenent WG, Bentley D, Burns P, Coffey A, Deloukas P, Earthrowl M, Farndale RW, Hoylaerts MF, Koch K, Rankin A, Rice CM, Rogers J, Samani NJ, Steward M, Walker A, Watkins NA, Akkerman JW, Dudbridge F, Goodall AH, Ouwehand WH (2009a) A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 114:1405–1416

    Article  PubMed  CAS  Google Scholar 

  • Jones CI, Garner SF, Moraes LA, Kaiser WJ, Rankin A, Ouwehand WH, Goodall AH, Gibbins JM (2009b) PECAM-1 expression and activity negatively regulate multiple platelet signaling pathways. FEBS Lett 583:3618–3624

    Article  PubMed  CAS  Google Scholar 

  • Kasirer-Friede A, Kahn ML, Shattil SJ (2007) Platelet integrins and immunoreceptors. Immunol Rev 218:247–264

    Article  PubMed  CAS  Google Scholar 

  • Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, Ruggeri ZM (2006) Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 4:2014–2021

    Article  PubMed  CAS  Google Scholar 

  • Lanza F (2006) Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet J Rare Dis 1:46

    Article  PubMed  Google Scholar 

  • Ma H, Hara A, Xiao CY, Okada Y, Takahata O, Nakaya K, Sugimoto Y, Ichikawa A, Narumiya S, Ushikubi F (2001) Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP(3). Circulation 104:1176–1180

    Article  PubMed  CAS  Google Scholar 

  • Mangin P, Yap CL, Nonne C, Sturgeon SA, Goncalves I, Yuan Y, Schoenwaelder SM, Wright CE, Lanza F, Jackson SP (2006) Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcRgamma deficiency. Blood 107:4346–4353

    Article  PubMed  CAS  Google Scholar 

  • Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B (2003) A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 197:41–49

    Article  PubMed  CAS  Google Scholar 

  • May F, Hagedorn I, Pleines I, Bender M, Vogtle T, Eble J, Elvers M, Nieswandt B (2009) CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 114:3464–3472

    Article  PubMed  CAS  Google Scholar 

  • Miura Y, Takahashi T, Jung SM, Moroi M (2002) Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 277:46197–46204

    Article  PubMed  CAS  Google Scholar 

  • Morel O, Morel N, Freyssinet JM, Toti F (2008) Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 19:9–23

    Article  PubMed  CAS  Google Scholar 

  • Mori J, Pearce AC, Spalton JC, Grygielska B, Eble JA, Tomlinson MG, Senis YA, Watson SP (2008) G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem 283:35419–35427

    Article  PubMed  CAS  Google Scholar 

  • Moshfegh K, Wuillemin WA, Redondo M, Lammle B, Beer JH, Liechti-Gallati S, Meyer BJ (1999) Association of two silent polymorphisms of platelet glycoprotein Ia/IIa receptor with risk of myocardial infarction: a case-control study. Lancet 353:351–354

    Article  PubMed  CAS  Google Scholar 

  • Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, Conley PB, Phillips DR, Hart MJ (2005) Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem 280:24680–24689

    Article  PubMed  CAS  Google Scholar 

  • Nergiz-Unal R, Rademakers T, Cosemans JM, Heemskerk JW (2011) CD36 as a multiple-ligand signaling receptor in atherothrombosis. Cardiovasc Hematol Agents Med Chem 9:42–55

    PubMed  CAS  Google Scholar 

  • Nurden AT (2006) Glanzmann thrombasthenia. Orphanet J Rare Dis 1:10

    Article  PubMed  Google Scholar 

  • Nurden P, Nurden AT (2008) Congenital disorders associated with platelet dysfunctions. Thromb Haemost 99:253–263

    PubMed  CAS  Google Scholar 

  • Nuyttens BP, Thijs T, Deckmyn H, Broos K (2011) Platelet adhesion to collagen. Thromb Res 127(Suppl 2):S26–S29

    Article  PubMed  CAS  Google Scholar 

  • Oestreich J (2009) SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis. Curr Opin Investig Drugs 10:988–996

    PubMed  CAS  Google Scholar 

  • Orlowski E, Chand R, Yip J, Wong C, Goschnick MW, Wright MD, Ashman LK, Jackson DE (2009) A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo. J Thromb Haemost 7:2074–2084

    Article  PubMed  CAS  Google Scholar 

  • Oury C, Sticker E, Cornelissen H, De Vos R, Vermylen J, Hoylaerts MF (2004) ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation. J Biol Chem 279:26266–26273

    Article  PubMed  CAS  Google Scholar 

  • Ozaki Y, Suzuki-Inoue K, Inoue O (2009) Novel interactions in platelet biology: CLEC-2/podoplanin and laminin/GPVI. J Thromb Haemost 7(Suppl 1):191–194

    Article  PubMed  CAS  Google Scholar 

  • Patrono C, Garcia Rodriguez LA, Landolfi R, Baigent C (2005) Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353:2373–2383

    Article  PubMed  CAS  Google Scholar 

  • Paul BZ, Ashby B, Sheth SB (1998) Distribution of prostaglandin IP and EP receptor subtypes and isoforms in platelets and human umbilical artery smooth muscle cells. Br J Haematol 102:1204–1211

    Article  PubMed  CAS  Google Scholar 

  • Philipose S, Konya V, Sreckovic I, Marsche G, Lippe IT, Peskar BA, Heinemann A, Schuligoi R (2010) The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation. Arterioscler Thromb Vasc Biol 30:2416–2423

    Article  PubMed  CAS  Google Scholar 

  • Pincus MR, Dykes DC, Carty RP, Miller JL (1991) Conformational energy analysis of the substitution of Val for Gly 233 in a functional region of platelet GPIb alpha in platelet-type von Willebrand disease. Biochim Biophys Acta 1097:133–139

    Article  PubMed  CAS  Google Scholar 

  • Pitchford SC, Yano H, Lever R, Riffo-Vasquez Y, Ciferri S, Rose MJ, Giannini S, Momi S, Spina D, O'Connor B, Gresele P, Page CP (2003) Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 112:109–118

    Article  PubMed  CAS  Google Scholar 

  • Poujol C, Ware J, Nieswandt B, Nurden AT, Nurden P (2002) Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model. Exp Hematol 30:352–360

    Article  PubMed  CAS  Google Scholar 

  • Prevost N, Woulfe D, Tognolini M, Brass LF (2003) Contact-dependent signaling during the late events of platelet activation. J Thromb Haemost 1:1613–1627

    Article  PubMed  CAS  Google Scholar 

  • Prevost N, Woulfe DS, Jiang H, Stalker TJ, Marchese P, Ruggeri ZM, Brass LF (2005) Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci USA 102:9820–9825

    Article  PubMed  CAS  Google Scholar 

  • Ramacciotti E, Hawley AE, Farris DM, Ballard NE, Wrobleski SK, Myers DD Jr, Henke PK, Wakefield TW (2009) Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost 101:748–754

    PubMed  CAS  Google Scholar 

  • Ramacciotti E, Blackburn S, Hawley AE, Vandy F, Ballard-Lipka N, Stabler C, Baker N, Guire KE, Rectenwald JE, Henke PK, Myers DD Jr, Wakefield TW (2011) Evaluation of soluble P-Selectin as a marker for the diagnosis of deep venous thrombosis. Clin Appl Thromb Hemost 17(4):425–431

    Article  PubMed  CAS  Google Scholar 

  • Ramakrishnan V, DeGuzman F, Bao M, Hall SW, Leung LL, Phillips DR (2001) A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. Proc Natl Acad Sci USA 98:1823–1828

    Article  PubMed  CAS  Google Scholar 

  • Rivera J, Lozano ML, Navarro-Nunez L, Vicente V (2009) Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94:700–711

    Article  PubMed  CAS  Google Scholar 

  • Roberts W, Magwenzi S, Aburima A, Naseem KM (2010) Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. Blood 116:4297–4306

    Article  PubMed  CAS  Google Scholar 

  • Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803–814

    Article  PubMed  CAS  Google Scholar 

  • Salsmann A, Schaffner-Reckinger E, Kieffer N (2006) RGD, the Rho'd to cell spreading. Eur J Cell Biol 85:249–254

    Article  PubMed  CAS  Google Scholar 

  • Santoro SA (1999) Platelet surface collagen receptor polymorphisms: variable receptor expression and thrombotic/hemorrhagic risk. Blood 93:3575–3577

    PubMed  CAS  Google Scholar 

  • Savage B, Almus-Jacobs F, Ruggeri ZM (1998) Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 94:657–666

    Article  PubMed  CAS  Google Scholar 

  • Senis YA, Tomlinson MG, Ellison S, Mazharian A, Lim J, Zhao Y, Kornerup KN, Auger JM, Thomas SG, Dhanjal T, Kalia N, Zhu JW, Weiss A, Watson SP (2009) The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis. Blood 113:4942–4954

    Article  PubMed  CAS  Google Scholar 

  • Siljander PR, Hamaia S, Peachey AR, Slatter DA, Smethurst PA, Ouwehand WH, Knight CG, Farndale RW (2004) Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem 279:47763–47772

    Article  PubMed  CAS  Google Scholar 

  • Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N (2003) Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes. Int J Cardiol 90:261–268

    Article  PubMed  Google Scholar 

  • Staron M, Wu S, Hong F, Stojanovic A, Du X, Bona R, Liu B, Li Z (2011) Heat-shock protein gp96/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex. Blood 117:7136–7144

    Article  PubMed  CAS  Google Scholar 

  • Stitham J, Stojanovic A, Hwa J (2002) Impaired receptor binding and activation associated with a human prostacyclin receptor polymorphism. J Biol Chem 277:15439–15444

    Article  PubMed  CAS  Google Scholar 

  • Stitham J, Arehart EJ, Gleim SR, Douville KL, Hwa J (2007) Human prostacyclin receptor structure and function from naturally-occurring and synthetic mutations. Prostaglandins Other Lipid Mediat 82:95–108

    Article  PubMed  CAS  Google Scholar 

  • Stitham J, Arehart E, Elderon L, Gleim SR, Douville K, Kasza Z, Fetalvero K, MacKenzie T, Robb J, Martin KA, Hwa J (2011) Comprehensive biochemical analysis of rare prostacyclin receptor variants: study of association of signaling with coronary artery obstruction. J Biol Chem 286:7060–7069

    Article  PubMed  CAS  Google Scholar 

  • Suzuki-Inoue K, Fuller GL, Garcia A, Eble JA, Pohlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, Theakston RD, Schweighoffer E, Zitzmann N, Morita T, Tybulewicz VL, Ozaki Y, Watson SP (2006) A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 107:542–549

    Article  PubMed  CAS  Google Scholar 

  • Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, Shin Y, Hirashima M, Ozaki Y (2010) Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 285:24494–24507

    Article  PubMed  CAS  Google Scholar 

  • Tamburrelli C, Crescente M, Izzi B, Barisciano M, Donati MB, de Gaetano G, Cerletti C (2011) Epoprostenol inhibits human platelet-leukocyte mixed conjugate and platelet microparticle formation in whole blood. Thromb Res 128(5):446–451

    Article  PubMed  CAS  Google Scholar 

  • Varga-Szabo D, Pleines I, Nieswandt B (2008) Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28:403–412

    Article  PubMed  CAS  Google Scholar 

  • Washington AV, Gibot S, Acevedo I, Gattis J, Quigley L, Feltz R, De La Mota A, Schubert RL, Gomez-Rodriguez J, Cheng J, Dutra A, Pak E, Chertov O, Rivera L, Morales J, Lubkowski J, Hunter R, Schwartzberg PL, McVicar DW (2009) TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans. J Clin Invest 119:1489–1501

    Article  PubMed  CAS  Google Scholar 

  • Wilson SJ, Roche AM, Kostetskaia E, Smyth EM (2004) Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. J Biol Chem 279:53036–53047

    Article  PubMed  CAS  Google Scholar 

  • Wilson SJ, Dowling JK, Zhao L, Carnish E, Smyth EM (2007) Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler Thromb Vasc Biol 27:290–296

    Article  PubMed  CAS  Google Scholar 

  • Wu G, Essex DW, Meloni FJ, Takafuta T, Fujimura K, Konkle BA, Shapiro SS (1997) Human endothelial cells in culture and in vivo express on their surface all four components of the glycoprotein Ib/IX/V complex. Blood 90:2660–2669

    PubMed  CAS  Google Scholar 

  • Wu YP, Vink T, Schiphorst M, van Zanten GH, IJsseldijk MJ, de Groot PG, Sixma JJ (2000) Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol 20:1661–1667

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The CMVB is supported by the “programmafinanciering KULeuven” (PF/10/014). Financial support was given by KU Leuven project GOA09/13.

Author information

Authors and Affiliations

  1. Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium

    Alexandre Kauskot & Marc F. Hoylaerts

  2. Center for Molecular and Vascular Biology, KU Leuven, Herestraat 49, 3000, Leuven, Belgium

    Marc F. Hoylaerts

Authors
  1. Alexandre Kauskot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marc F. Hoylaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marc F. Hoylaerts .

Editor information

Editors and Affiliations

  1. , Department of Internal Medicine, University of Perugia, Via E. dal Pozzo, Perugia, 06126, Italy

    Paolo Gresele

  2. Institute, The William Harvey Research, Charterhouse Square, London, EC1M6BQ, United Kingdom

    Gustav V. R Born

  3. Istituto di Farmacologia, Università Cattolica del S. Cuore, Largo F. Vito 1, Roma, 00168, Italy

    Carlo Patrono

  4. King's College London, Sackler Inst. Pulmonary Pharmacology, Waterloo Campus, London, SE1 9NH, United Kingdom

    Clive P. Page

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kauskot, A., Hoylaerts, M.F. (2012). Platelet Receptors. In: Gresele, P., Born, G., Patrono, C., Page, C. (eds) Antiplatelet Agents. Handbook of Experimental Pharmacology, vol 210. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29423-5_2

Download citation

Publish with us

Policies and ethics

Search

Navigation